Dimension scores are derived from public data and fields; weighted into the composite. Reference only.
Encompass Pharmaceutical Services, Inc. is a privately held pharmaceutical services company based in Peachtree Corners, Georgia, USA, founded in 2003. According to its website, its focus areas include analytical chemistry, drug quality, method development, and ophthalmic drug development, and it describes itself as an FDA-inspected GMP analytical services organization. In terms of business scope, it is closer to a drug analysis and formulation development service provider within pharmaceutical R&D outsourcing/CRO.
Its analytical services are fairly broad, including finished product testing according to standards such as USP, PhEur, and JP; testing of excipients, APIs, and intermediates; analytical method transfer; particulate testing; potency and impurity method development; and method validation under ICH guidelines. For stability services, it provides ICH-compliant stability storage, project execution, stability testing, trend analysis, and annual GMP stability reviews. The website also lists packaging system characterization, extractables/leachables testing, plastic physical and chemical testing, container closure integrity, cleaning validation, and regulatory consulting. Another notable specialty is ophthalmic drug development and formulation services, covering parts of the process from pre-formulation through production scale-up.
The website does not disclose standard pricing, nor does it provide packages or an online ordering option. GMP testing and formulation development of this kind are typically highly project-based, with quotes depending on sample type, testing items, validation depth, target regulatory market, stability study duration, report format, and turnaround time. Prospective clients need to submit their requirements by email or through the contact form to obtain a customized quote.
Its strengths lie in its professional positioning, with clearly defined capabilities around drug analysis, quality compliance, and ophthalmic formulations. Its services cover laboratory testing, validation, stability, and quality consulting, making it suitable for pharmaceutical projects that require external laboratory support during development. Its statements regarding GMP compliance and FDA inspection may also be attractive to pharmaceutical companies.
The drawbacks are that the website provides limited information. It does not show detailed qualification certificates, instrument platforms, team backgrounds, client case studies, sample quality system documents, or typical delivery timelines. For overseas clients, especially those in China, details around cross-border sample shipment, contract procedures, payment methods, and communication support are also unclear.
It is suitable for small and mid-sized pharmaceutical companies, ophthalmic drug R&D teams, CMO/CDMO partners, projects requiring GMP analytical method development and validation, and companies seeking quality and validation consulting before regulatory submission or audits.
Judging by the website format, it is a standard English-language corporate website that uses Google reCAPTCHA and cookie notices. It can usually be accessed directly from mainland China, but Google-related components in the forms may occasionally fail to load properly. For formal cooperation, direct communication by email is still recommended.
⚠ This review is compiled from public sources and does not constitute a purchase recommendation. Verify all facts on the vendor's official site. Verify on encompass-pharma.com official site.
encompass-pharma.com is an United States Health provider. TG4G tracks its product information, an overall rating of 6.0/10, and a China-accessibility score of China direct-connect friendly. Click "Visit Official Site" to reach encompass-pharma.com directly.